In vitro expression of MMP-2 and MMP-9 in glioma cells following exposure to inflammatory mediators

被引:62
作者
Esteve, PO
Tremblay, P
Houde, M
St-Pierre, Y
Mandeville, R
机构
[1] Univ Quebec, Inst Armand Frappier, Ctr Rech Immunol, Laval, PQ H7N 4Z3, Canada
[2] Biochem ImmunoSyst, Montreal, PQ H3M 3A2, Canada
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 1998年 / 1403卷 / 01期
关键词
gelatinase; interleukin-1; tumor necrosis factor-alpha; transforming growth factor-beta; C6; glioma;
D O I
10.1016/S0167-4889(98)00020-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Progression of glioma is associated with local degenerative processes which are attributed to the activity of gelatinases. As glioma cells are candidate for secretion of these enzymes, we have studied in vitro the potential of cytokines (interleukin-1 alpha (IL-1), tumor necrosis factor-alpha (TNF alpha) and transforming growth factor-beta (TGF beta(2))) to regulate the expression of gelatinase A and B (Gels A and B, respectively) in two glioma cells of human (A172) and rat origin (C6). We showed that IL-1 and TNF alpha both induced gene expression and protein secretion of Gel B in both cell lines, as revealed by RT-PCR and gelatin zymography, respectively. In C6 cells, TNF alpha had no effect on Gel A constitutive expression while IL-1 increased its production, but only at high doses. We have also demonstrated that TGF beta(2) inhibited both IL-1- or TNF alpha-induced gene expression and Gel B production in a dose-dependent manner but had no effect on Gel A secretion. The effect of TGF beta(2) on Gel B secretion was reversed by phorbol myristate acetate (PMA). Taken together, these data suggest that IL-1, TNF alpha and TGF beta(2) tightly regulate Gel B secretion in glioma cells, an enzyme which is believed to play an important role in the local invasion of brain tissue by tumor cells. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:85 / 96
页数:12
相关论文
共 38 条
[1]   BINDING OF GELATINASES A AND B TO TYPE-I COLLAGEN AND OTHER MATRIX COMPONENTS [J].
ALLAN, JA ;
DOCHERTY, AJP ;
BARKER, PJ ;
HUSKISSON, NS ;
REYNOLDS, JJ ;
MURPHY, G .
BIOCHEMICAL JOURNAL, 1995, 309 :299-306
[2]  
APODACA G, 1990, CANCER RES, V50, P2322
[3]  
BODMER S, 1989, J IMMUNOL, V143, P3222
[4]  
CHEN CC, 1995, J NEUROCHEM, V64, P818
[5]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[6]  
COTTAM DW, 1993, INT J ONCOL, V2, P861
[7]  
FRIDMAN R, 1995, CANCER RES, V55, P2548
[8]   EXPRESSION AND RELEASE OF INTERLEUKIN-1 BY HUMAN GLIOBLASTOMA CELLS-INVITRO AND INVIVO [J].
GAUTHIER, T ;
HAMOU, MF ;
MONOD, L ;
GALLAY, P ;
CARREL, S ;
DETRIBOLET, N .
ACTA NEUROCHIRURGICA, 1993, 121 (3-4) :199-205
[9]   Glioma invasion in the central nervous system [J].
Giese, A ;
Westphal, M .
NEUROSURGERY, 1996, 39 (02) :235-250
[10]   DIFFERENTIAL REGULATION OF GELATINASE-B AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR EXPRESSION IN HUMAN BOWES MELANOMA-CELLS [J].
HOUDE, M ;
DEBRUYNE, G ;
BRACKE, M ;
INGELMANSUNDBERG, M ;
SKOGLUND, G ;
MASURE, S ;
VANDAMME, J ;
OPDENAKKER, G .
INTERNATIONAL JOURNAL OF CANCER, 1993, 53 (03) :395-400